Patent · US Active

Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens

US8053553B2 · kind B2 · utility

2Cited by

0References

21Claims

0Family size

Assignees

SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. · CA
Illumina, Inc. · US
Sanford-Burnham Medical Research Institute · US

Inventors

Alex Strongin · San Diego, US
Michal Lebl · Oro Valley, US
Robert Day · Deux-Montagnes, CA

Key dates

Filing date	May 5, 2008
Grant date	Nov 8, 2011
Priority date	—
Expiry date	Aug 11, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compositions and methods for preventing or reducing harm resulting from pathogen infection. For example, disclosed are peptides that inhibit the processing of toxins normally cleaved by proprotein convertase enzymes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.